Study on software to improve team meetings
Part of Cancer clinical trials.
This trial tests a new software tool designed to help medical teams work together more effectively and safely during multi-disciplinary meetings. If you are part of a medical team that holds these meetings, your participation could help improve how decisions are made.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a member of a multi-disciplinary team (MDT) that holds regular meetings.
- You are a coordinator or staff member who submits referrals to these meetings.
- You are willing and able to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well new computer methods (called algorithms and machine learning) can support radiation therapy decisions. You might benefit by helping improve how radiation is planned and checked, especially for cancers treated with curative-intent therapy.
This study watches how doctors from different specialties communicate and make decisions together during team meetings about ovarian and uterine cancer care. Researchers want to understand what makes these team discussions work well.
This research study asks newly diagnosed cancer patients (with breast, pancreatic, or gynecologic cancer) to share their symptoms and concerns through simple surveys. The goal is to see if adding this patient feedback during doctor team meetings leads to better care.
This study compares treatment recommendations from a computer system with those from a team of cancer doctors. It may help improve how cancer care decisions are made.
This trial tests a program called TeamTalk to help healthcare teams communicate better when caring for hospitalized children with cancer. It aims to improve teamwork and care quality.
This trial sets up a “molecular tumor board,” a team that reviews your tumor’s lab results and helps your doctor choose treatment options. It may help by making sense of tumor test findings so decisions are more personalized.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.